Trump Keeps Options Open, But He’s Not Expected To Back Govt. Negotiation Again

By John Wilkerson / February 18, 2020 at 11:43 AM
The president is keeping his options open on drug pricing legislation, but sources doubt he’ll return to backing Medicare price negotiation, even if his primary challenger is Democratic Socialist Sen. Bernie Sanders, who would likely attack President Donald Trump for not following through on his 2016 campaign promise to negotiate cheaper drug prices. Acting Director of the White House’s Office of Management and Budget Russell Vought said Feb. 10 in an NPR interview that the president’s proposed budget does not...


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.